6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
|
|
|
- CAS番号.
- 1812890-23-5
- 化学名:
- 别名:
- 英語名:
- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- 英語别名:
- Tofatinib Impurity 17;Tofacitinib Related Compound 23;Azilsartan medoxomil impurity319;Tofacitinib Hydrogenation Impurities;(6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-methyl-(4-methyl-piperidin-3-yl)-amine;6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine;5H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6,7-dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity)
- CBNumber:
- CB53143734
- 化学式:
- C13H21N5
- 分子量:
- 247.34
- MOL File:
- 1812890-23-5.mol
|
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 物理性質
- 沸点 :
- 435.9±45.0 °C(Predicted)
- 比重(密度) :
- 1.137±0.06 g/cm3(Predicted)
- 溶解性:
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- 外見 :
- Solid
- 酸解離定数(Pka):
- 9.48±0.10(Predicted)
- 色:
- Off-White to Pale Yellow
安全性情報
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 価格
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 化学特性,用途語,生産方法
使用
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine is an intermediate (reagent) in the preparation of Tofacitinib analog compounds.
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 上流と下流の製品情報
原材料
準備製品
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 生産企業
Global( 35)Suppliers
1812890-23-5()キーワード:
(S)-4-クロロ-3-ヒドロキシ酪酸 エチル
(S)-N4-(3-クロロ-4-フルオロフェニル)-7-((テトラヒドロフラン-3-イル)オキシ)キナゾリン-4,6-ジアミン
(3S,4S)-1-ベンジル-N,4-ジメチルピペリジン-3-アミン
2,6-ジクロロ-7-デアザプリン
2-クロロ-N-(2,5-ジメチルフェニル)アセトアミド
トファシチニブクエン酸塩
2-クロロ-N-(2,3-ジメチルフェニル)アセトアミド
クロロ-N-(2,4-ジメチルフェニル)アセトアミド
N-((3R,4R)-1-ベンジル-4-メチルピペリジン-3-イル)-N-メチル-7-トシル-7H-ピロロ[2,3-D]ピリミジン-4-アミン
N-メチル-N-((3R,4R)-4-メチルピペリジン-3-イル)-7H-ピロロ[2,3-D]ピリミジン-4-アミン
1-ベンジル-N,4-ジメチルピペリジン-3-アミン
- 1812890-23-5
- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- Tofacitinib Related Compound 23
- 5H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6,7-dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-
- Azilsartan medoxomil impurity319
- Tofacitinib Hydrogenation Impurities
- (6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-methyl-(4-methyl-piperidin-3-yl)-amine
- Tofatinib Impurity 17
- N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity)